000 01346 a2200337 4500
005 20250515072608.0
264 0 _c20080228
008 200802s 0 0 eng d
022 _a1619-7070
024 7 _a10.1007/s00259-007-0483-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHindiƩ, Elif
245 0 0 _aPredicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: prognostic value and possible role in patient management.
_h[electronic resource]
260 _bEuropean journal of nuclear medicine and molecular imaging
_cOct 2007
300 _a1576-82 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aEsophageal Neoplasms
_xdiagnostic imaging
650 0 4 _aFluorodeoxyglucose F18
650 0 4 _aHumans
650 0 4 _aPositron-Emission Tomography
_xmethods
650 0 4 _aPrognosis
650 0 4 _aRadiopharmaceuticals
650 0 4 _aRadiotherapy
_xmethods
650 0 4 _aRectal Neoplasms
_xdiagnostic imaging
650 0 4 _aTreatment Outcome
700 1 _aHennequin, Christophe
700 1 _aMoretti, Jean-luc
773 0 _tEuropean journal of nuclear medicine and molecular imaging
_gvol. 34
_gno. 10
_gp. 1576-82
856 4 0 _uhttps://doi.org/10.1007/s00259-007-0483-5
_zAvailable from publisher's website
999 _c17117419
_d17117419